Expansion of Overseas Bases and Acceleration of Pesticide Registrations in Each Country
First written in FY2016. 16 of 18 entries say "Advanced", first in FY2017. Latest entry: FY2026.
96 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Registration applications in Japan and South Korea have been completed for the new broad-spectrum insecticide cybenzoxasulfyl. Pyrifluquinazon was also newly launched in Tunisia, Libya, Israel and Vietnam, and registered in Chile and Morocco.」
In addition to completing registration applications for the new product in Japan and South Korea, overseas launches and registrations of key products progressed, expanding the countries of registration and sales regions. - 2026-05-13AdvancedRevision of earnings forecasts
「Building on the direct-sales structure established in the UK and Ireland in the previous fiscal year, we will work to expand sales of crop protection products, adjuvants, biostimulants, and other products, including products manufactured by Interagro (UK) Ltd., with which we integrated our operations.」
The Company is expanding sales across multiple fields, including integrated Interagro products, using its direct-sales structure in the UK and Ireland as a base. - FY2025AdvancedAnnual report
「The insecticide pyrifluquinazon was newly launched in the Dominican Republic, Tunisia, Libya, Israel, Canada, Nicaragua and El Salvador. Registration was also obtained in Chile (registered in August 2024) and Vietnam (registered in February 2025), and preparations are under way for sales launches during 2025.」
Sales launches and registrations for pyrifluquinazon and other products progressed in multiple countries, expanding the overseas registration and sales footprint. - FY2024-Q3AdvancedAnnual report
「As a key initiative during the third quarter, the company established a local subsidiary in Chile in October 2023 to strengthen and expand its business activities there. In December of the same year, it launched Orchestra Duet, a new combination product containing the rice insecticide benspyrimoxan, in India.」
The company established a local subsidiary in Chile to strengthen and expand its business activities and launched a new benspyrimoxan combination product in India, advancing its overseas bases and product rollout. - FY2024-Q2AdvancedAnnual report
「In India, the consolidated subsidiary Nichino India Pvt. Ltd. registered a new combination formulation of the new paddy-rice insecticide benzpyrimoxan, and a multipurpose plant capable of manufacturing multiple active ingredients was completed. The plant is scheduled to begin operations during the current fiscal year.」
In India, the company registered a new combination product containing benspyrimoxan and reached the stage of completing a plant capable of manufacturing multiple pesticide active ingredients. - FY2024-Q1AdvancedAnnual report
「As a key initiative during the cumulative first quarter, Nichino Europe Co., Ltd., a consolidated subsidiary of the company, acquired all issued shares of Interagro (UK) Limited, a UK-based manufacturer and distributor of adjuvants and other additives and biostimulants, with the aim of expanding the business portfolio beyond chemically synthesized pesticides.」
Through Nichino Europe, the company acquired all issued shares of UK-based Interagro and expanded its overseas bases and product portfolio. - FY2023AdvancedAnnual report
「The insecticide flubendiamide is under consideration for further business expansion, and registration has been obtained in Argentina and the Philippines, following Brazil, a major market.」
Overseas registrations and sales regions expanded, including registration of flubendiamide in Argentina and the Philippines, launches and registrations of pyrifluquinazon in multiple countries, and registration of pyraziflumid in Canada. - FY2023-Q2AdvancedAnnual report
「The Group's main initiative during the second quarter of the current cumulative consolidated period was the launch of full-scale sales of the new paddy-rice insecticide benzpyrimoxan in India, together with technical extension activities to expand sales.」
With the full-scale launch of the new rice insecticide in India and technical outreach activities, overseas product development has progressed to the post-registration, post-launch expansion stage. - FY2022AdvancedAnnual report
「The insecticide pyrifluquinazon was newly launched in Colombia. Registration was also obtained in India, Algeria and Oman, while registration reviews are under way in Israel, Saudi Arabia, the UAE and Taiwan. The company will continue working to expand the countries and regions in which the product is registered.」
The registration and sales footprint expanded, including the launch of pyrifluquinazon in Colombia and registration obtained in India, Algeria and Oman. - FY2022-Q1AdvancedAnnual report
「In May this year, we began selling the new paddy rice insecticide benzpyrimoxan, marketed as Orchestra, which obtained pesticide registration in Japan in September last year.」
The new rice insecticide progressed from registration in Japan to the launch stage. - FY2021AdvancedAnnual report
「In Japan, the new mode of action was highly rated, and the product was granted priority review. As a result, pesticide registration was obtained earlier than usual, in September 2020, for Orchestra Flowable and Orchestra Dust DL. Orchestra Flowable sales began in May 2021.」
The products advanced through the registration and launch stages in Japan, with pesticide registration obtained and sales commenced. - FY2021-Q2AdvancedAnnual report
「Benzpyrimoxan, a new insecticide for paddy rice independently invented by the company and for which applications for agricultural chemical registration were filed in Japan and India in February 2019, obtained agricultural chemical registration in Japan on 14 September of this year under the domestic product name Orchestra. Sales are scheduled to begin in May 2021.」
For the products filed for simultaneous registration in Japan and India, the company reported that registration had been obtained in Japan and that sales were scheduled to begin in May 2021. - FY2019-Q4AdvancedAnnual report
「The horticultural insecticide Colt was registered for food-use applications in the United States last November, and Nichino America, Inc. began sales in this field.」
Colt advanced through the registration and launch stages, with food-use registration obtained in the United States and sales launched by Nichino America. - FY2018AdvancedAnnual report
「February 2018: Acquired all shares of Adnicol S.A.S. (now Nihon Nohyaku Andica S.A.S.) (now an unconsolidated subsidiary)」
The company acquired all shares of Colombia-based Adnicol and expanded its overseas operations. It also reported progress and plans for registrations in various countries, including domestic registration of Parade, registration in South Korea and plans to file for registration in the United States. - FY2019-Q1RestatedAnnual report
「In domestic agrochemical sales, the company began selling Parade, a new fungicide, expanded its product portfolio in the herbicide segment, and worked to promote and expand sales of core internally developed products.」
The company has reaffirmed the launch of Parade and the expansion of its product portfolio. Since registration and the launch had already been reported in the previous filing, they were reiterated this time. - FY2018-Q4AdvancedAnnual report
「The new in-house-developed horticultural fungicide Parade, which had been under development for some time, was registered in March this year and launched in April.」
The new in-house-developed product Parade advanced to the registration and launch stages, with registration obtained and sales commenced. - FY2017AdvancedAnnual report
「Development of the new rice insecticide benspyrimoxan (NNI-1501) is progressing on schedule through collaboration with HCL, with the aim of simultaneously filing for registration in Japan and India in 2018.」
The company has presented specific plans to accelerate registrations in each country, including simultaneous registration filings in Japan and India through collaboration with HCL and registration filings for pyraziflumid in South Korea and the United States. - FY2016First statedAnnual report
「In overseas markets, where continued growth is expected, we will continue expanding our bases in key markets in addition to the investments in overseas bases made under the previous medium-term management plan, and work toward steady growth in our overseas business.」
The company plans to continue expanding its bases in key markets in addition to investing in its existing overseas bases.